A61P 37 - Drugs for immunological or allergic disorders

Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
10/2002
10/30/2002	EP1251750A1 Improved pediatric formula and methods for providing nutrition and improving tolerance
10/30/2002	EP0854863B1 Esters and amides as pla2 inhibitors
10/30/2002	EP0812195B1 Pharmaceutical composition for piperidinoalkanol compounds
10/30/2002	EP0726911B1 Treatment of hematologic disorders with a igf-1/igfbp-3 complex
10/30/2002	EP0689449B1 Therapeutical compositions for use in humans, characterised by a combination of a muramyl peptide and a cytokine
10/30/2002	CN1377424A Methods of reparing tandemly repeated DNA sequences and extending cell life-span using nuclear transfer
10/30/2002	CN1377353A Purine derivatives having phosphodiesterase IN inhibition activity
10/30/2002	CN1377352A Selective antagonists of A28 adenosine receptors
10/30/2002	CN1377347A 药学活性磺酰胺衍生物 Pharmaceutically active sulfonamide derivatives
10/30/2002	CN1377346A Z-pyrazoline-5-ones
10/30/2002	CN1377344A Inhibitor of cysteinyl aspartic acid proteinase
10/30/2002	CN1377279A Use of soluble cosmetimulatory molecules to enhance immune responses
10/30/2002	CN1377278A Prevention and treatment of amyloidogenic disease
10/30/2002	CN1377271A Use of thienopyrimidines
10/30/2002	CN1377268A Cell adhesion inhibitors
10/30/2002	CN1377261A Treatment of immune diseases
10/30/2002	CN1377259A ACE-2 inhibiting compounds and methods of use thereof
10/30/2002	CN1377235A Nutritional compositions which contain non-digestible polysaccharides and use thereof to reduce transport through tight junctions
10/30/2002	CN1093536C 5-lipoxygenase inhibitor
10/30/2002	CA2383469A1 Treatment of t-cell mediated diseases
10/29/2002	US6472511 Stimulation of an immune response with antibodies labeled with the α-galactosyl epitope
10/29/2002	US6472506 Polysaccharide-peptide-conjugates
10/29/2002	US6472418 Non-peptide NK1 receptors antagonists
10/29/2002	US6472412 Compounds as PDE IV and TNF inhibitors
10/29/2002	US6472386 Cyclic diamine compound with 5-membered ring groups
10/29/2002	US6472172 DNA encoding a novel human inhibitor-of-apoptosis protein
10/29/2002	US6472159 Use of an amphipathic compound for providing an adjuvant to a subunit vaccine
10/29/2002	US6471997 Antagonist of calcitonin gene related peptide, cgrp and/or of substance p; cosmetic
10/29/2002	US6471967 Recombinant intracellular pathogen vaccines and methods for use
10/29/2002	US6471959 Human transferase
10/29/2002	US6471957 Canine IL-4 immunoregulatory proteins and uses thereof
10/29/2002	CA2088128C Salts of glucopyranose derivatives and its intermediate
10/25/2002	WO2001078652A2 Methods for drug discovery, disease treatment, and diagnosis using metabolomics
10/25/2002	EP1194142A4 Salts of cis -4-cyano-4-(3-cyclopentyloxy-4-methoxyphenyl) cyclohexan-1-carboxylate!
10/25/2002	CA2443806A1 Methods for drug discovery, disease treatment, and diagnosis using metabolomics
10/24/2002	WO2002084249A2 Therapeutic and diagnostic uses of antibody specificity profiles
10/24/2002	WO2002083946A1 Method of examining allergic disease
10/24/2002	WO2002083879A2 Immunotherapy based on dendritic cells
10/24/2002	WO2002083873A2 Enzymes
10/24/2002	WO2002083870A2 Pufa polyketide synthase systems and uses thereof
10/24/2002	WO2002083855A2 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
10/24/2002	WO2002083854A2 Antibodies to vla-1
10/24/2002	WO2002083841A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/24/2002	WO2002083736A2 G-protein coupled receptor molecules and uses thereof
10/24/2002	WO2002083720A2 Intermediates and enzymes of the non-mevalonate isoprenoid pathway
10/24/2002	WO2002083712A2 Transporters and ion channels
10/24/2002	WO2002083709A2 Kinases and phosphatases
10/24/2002	WO2002083704A1 Vascular endothelial growth factor 2
10/24/2002	WO2002083700A2 Hypersulfated disaccharides and methods of using the same for the treatment of inflammations
10/24/2002	WO2002083696A2 Novel cyclo azaphospha hydrocarbons
10/24/2002	WO2002083668A1 Isoxaxole derivatives as inhibitors of src and other protein kinases
10/24/2002	WO2002083667A2 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
10/24/2002	WO2002083664A1 3-substituted quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
10/24/2002	WO2002083663A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
10/24/2002	WO2002083648A1 Novel 1h-indazole compound
10/24/2002	WO2002083646A1 Lactam compounds for penetration enhancement
10/24/2002	WO2002083645A1 Novel compounds
10/24/2002	WO2002083642A1 Compounds useful as anti-inflammatory agents
10/24/2002	WO2002083628A1 1,4-disubstituted benzo-fused compounds
10/24/2002	WO2002083627A2 Ligands des integrins avss6
10/24/2002	WO2002083624A1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands
10/24/2002	WO2002083616A1 α-SUBSTITUTED φ-ARYLFATTY ACID DERIVATIVE
10/24/2002	WO2002083186A1 Nuclear receptor-mediated introduction of a pna into cell nuclei
10/24/2002	WO2002083185A1 Method of gene transfer via vascular system or ureter
10/24/2002	WO2002083166A1 Interferon-polymer complexes and medicinal use thereof
10/24/2002	WO2002083152A1 Activation of natural killer cells by adenosine a3 receptor agonists
10/24/2002	WO2002083143A1 Cxcr3 antagonists
10/24/2002	WO2002083128A1 2,1-oxazoline and 1,2-pyrazoline-based inhibitors of dipeptidyl peptidase iv and method
10/24/2002	WO2002083122A1 Fatty alcohols and fatty acid esters useful for treatment of inflammation
10/24/2002	WO2002083121A1 Compositions for improving skin environment and clothes thereof
10/24/2002	WO2002083103A2 Pharmaceutical product with reticulated crystalline microstructure
10/24/2002	WO2002083072A2 Methods and compositions for stable transgenic plant pharmaceuticals and their use as contraceptives
10/24/2002	WO2002074244A3 Transcutaneous immunostimulation
10/24/2002	WO2002060931A3 A fimbria-like gene in bifidobacteria
10/24/2002	WO2002053140A3 New drug combinations of norepinehrine reuptake inhibitors and neuroleptic agents
10/24/2002	WO2002051848A3 Sulfamidothienopyrimidines and the use of the same as phosphodiesterase v inhibitors
10/24/2002	WO2002050065A3 Pyrazole compounds useful as protein kinase inhibitors
10/24/2002	WO2002040038A3 M. tuberculosis chaperonin 10 and uses thereof
10/24/2002	WO2002026258A3 Treatment of immune-mediated diseases by oral administration of plasma fractions
10/24/2002	WO2002024659A3 Substituted imidazoles as dual histamine h1 and h3 agonists or antgonists
10/24/2002	WO2002017935A3 A method of transplantation using chemotherapy-treated allogeneic cells that enhance immune responses without graft versus host disease
10/24/2002	WO2001085206A3 Immunosuppressive compositions comprising an immunophilin-binding compound and a gingkolide compound
10/24/2002	WO2001076568B1 Use of 13-hode as a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia
10/24/2002	WO2001074848A3 Immunodominant acetylcholine receptor alpha subunit peptides, complexes thereof with mhc class ii components and their use
10/24/2002	WO2001062793A9 Estrogen receptor beta variants and methods of detection thereof
10/24/2002	WO2001060778A9 Aspirin-triggered lipid mediators
10/24/2002	WO2001058526A9 Mixtures of caspase inhibitors and complement inhibitors and methods of use thereof
10/24/2002	WO2001055337A3 Methods and materials relating to carcinoembryonic antigen-like (cea-like) polypeptides and polynucleotides
10/24/2002	US20020156314 Aryl phenylcyclopropyl sulfide derivatives and their use as cell adhesion inhibiting anti-inflammatory and immune suppressive agents
10/24/2002	US20020156292 Anticancer agents
10/24/2002	US20020156264 And method of using the carboxypeptidase polypeptides and polynucleotides as a target for diagnosis and treatment in carboxypeptidase-related disorders
10/24/2002	US20020156258 Transcription factor of MHC class II genes, substances capable of inhibiting this new transcription factor and medical uses of these substances
10/24/2002	US20020156122 Statins (HMG-CoA reductase inhibitors) as a novel type of immunomodulator, immunosuppressor and anti-inflammatory agent
10/24/2002	US20020156104 Novel pyrazole and pyrazoline substituted compounds
10/24/2002	US20020156102 Piperidine amides as modulators of chemo kine receptor activity
10/24/2002	US20020156099 1-acyl-piperidine substance p antagonist; used to treat central nervous system disorders and respiratory diseases
10/24/2002	US20020156081 Pyrazolopyrimidines as therapeutic agents
10/24/2002	US20020156067 New drug combinations
10/24/2002	US20020156030 Heterocyclic aromatic compounds and uses thereof
10/24/2002	US20020156024 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof

1 ... 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 786 787 788 789 ... 1172